Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MPLT
MPLT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MPLT News
Biotech Sector Update: FDA and EU Approvals
Jun 26 2026
NASDAQ.COM
Raymond James Initiates Strong Buy Ratings for Tonix and MapLight
Jun 25 2026
seekingalpha
MapLight Therapeutics Appoints New Board Members
Jun 24 2026
Newsfilter
MapLight's Autism Drug Trial Fails to Meet Primary Endpoint
Jun 22 2026
NASDAQ.COM
FCPM III Reduces Stake in Dyne Therapeutics by $14 Million
May 30 2026
Yahoo Finance
Wall Street's Latest Rating Changes Overview
May 27 2026
CNBC
MapLight CFO's Stock Sale Raises Investor Concerns
May 15 2026
Fool
MapLight Therapeutics Reports Q1 Losses and Cash Position
May 15 2026
seekingalpha
MapLight Therapeutics Executive Sells Shares
May 04 2026
Fool
MapLight Completes Enrollment in Schizophrenia Trial
May 01 2026
NASDAQ.COM
Analysis of MapLight Therapeutics' Cash Burn
Apr 26 2026
Yahoo Finance
MapLight Therapeutics Executive Sells Shares Amid Routine Liquidity Management
Apr 22 2026
Fool
Biotech Stocks Reach New 52-Week Highs
Apr 09 2026
NASDAQ.COM
MapLight Reports 2025 Financial Results and Clinical Milestones
Mar 26 2026
NASDAQ.COM
MapLight Therapeutics Reports Q4 Financial Results
Mar 26 2026
seekingalpha
Maplight Therapeutics Inc. Reports Q4 Net Loss of $79.5 Million, Q4 EPS at -$2.47
Mar 26 2026
moomoo
Show More News
